메뉴 건너뛰기




Volumn 17, Issue 6, 2011, Pages 683-685

Incidence of severe adverse events requiring hospital care after trastuzumab infusion for metastatic breast cancer: A nationwide survey using an administrative claim database

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; DOCETAXEL; NAVELBINE; PACLITAXEL; TRASTUZUMAB;

EID: 80755133435     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2011.01170.x     Document Type: Letter
Times cited : (7)

References (6)
  • 2
    • 34347395733 scopus 로고    scopus 로고
    • Trastuzumab - Mechanism of action and use in clinical practice
    • DOI 10.1056/NEJMra043186
    • Hudis CA,. Trastuzumab-mechanism of action and use in clinical practices. N Engl J Med 2007; 357: 39-51. (Pubitemid 47026733)
    • (2007) New England Journal of Medicine , vol.357 , Issue.1 , pp. 39-51
    • Hudis, C.A.1
  • 6
    • 0034878178 scopus 로고    scopus 로고
    • Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe
    • Piccart MJ,. Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe. Ann Oncol 2001; 12 (Suppl 1): S89-94. (Pubitemid 32750591)
    • (2001) Annals of Oncology , vol.12 , Issue.SUPPL. 1
    • Piccart, M.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.